Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Treated with Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone: an Analysis of Patient-Reported Outcomes from the Phase 3 CANDOR Trial.
Clinical lymphoma, myeloma & leukemia（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined